The American Journal of Medicine
Volume 119, Issue 10 , Pages 820-823, October 2006

Allergy Immunotherapy for Primary Care Physicians

  • Jeffrey R. Stokes, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Jeffrey R. Stokes, MD, Creighton University, Department of Medicine, 601 No. 30 St., Suite 5850, Division of Allergy/Immunology, Omaha, NE 68131.
    • ,
  • Thomas B. Casale, MD

Creighton University, Division of Allergy/Immunology, Omaha, Neb.

Received 3 February 2006; received in revised form 14 February 2006; accepted 14 February 2006.

Abstract 

Allergic diseases affect a large proportion of the population of the United States. Although there are many effective pharmacologic therapies available, only allergen-specific immunotherapy has been shown to have significant and long-lasting therapeutic and immunomodulatory effects for the management of allergic rhinitis, allergic asthma, and venom hypersensitivity. Allergen immunotherapy requires a build-up phase as the dose of the vaccine is increased until a therapeutic (maintenance) level is achieved. This maintenance dose is usually continued for 3 to 5 years. Most patients tolerate immunotherapy well, but local reactions are not uncommon. Immunotherapy should only be administered in a physician’s office because some patients may experience systemic anaphylactic reactions requiring immediate therapy. Even with newer therapies on the horizon, allergen immunotherapy will continue to have an important role in the treatment of allergic diseases.

Keywords: Immunotherapy, Allergy, Rhinitis, Insect Hypersensitivity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9343(06)00203-8

doi:10.1016/j.amjmed.2006.02.019

The American Journal of Medicine
Volume 119, Issue 10 , Pages 820-823, October 2006

Article Tools